EP1185266A4 - Amorphous form of fexofenadine hydrochloride - Google Patents

Amorphous form of fexofenadine hydrochloride

Info

Publication number
EP1185266A4
EP1185266A4 EP00927651A EP00927651A EP1185266A4 EP 1185266 A4 EP1185266 A4 EP 1185266A4 EP 00927651 A EP00927651 A EP 00927651A EP 00927651 A EP00927651 A EP 00927651A EP 1185266 A4 EP1185266 A4 EP 1185266A4
Authority
EP
European Patent Office
Prior art keywords
amorphous form
fexofenadine hydrochloride
fexofenadine
hydrochloride
amorphous
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP00927651A
Other languages
German (de)
French (fr)
Other versions
EP1185266A1 (en
Inventor
Naresh Kumar
Chandras Has Khanduri
Mukesh Sharma
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ranbaxy Laboratories Ltd
Original Assignee
Ranbaxy Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Laboratories Ltd filed Critical Ranbaxy Laboratories Ltd
Publication of EP1185266A1 publication Critical patent/EP1185266A1/en
Publication of EP1185266A4 publication Critical patent/EP1185266A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
EP00927651A 1999-05-25 2000-05-25 Amorphous form of fexofenadine hydrochloride Withdrawn EP1185266A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN776DE1999 IN191492B (en) 1999-05-25 1999-05-25
INDE077699 1999-05-25
PCT/IB2000/000708 WO2000071124A1 (en) 1999-05-25 2000-05-25 Amorphous form of fexofenadine hydrochloride

Publications (2)

Publication Number Publication Date
EP1185266A1 EP1185266A1 (en) 2002-03-13
EP1185266A4 true EP1185266A4 (en) 2002-07-17

Family

ID=11091185

Family Applications (1)

Application Number Title Priority Date Filing Date
EP00927651A Withdrawn EP1185266A4 (en) 1999-05-25 2000-05-25 Amorphous form of fexofenadine hydrochloride

Country Status (4)

Country Link
EP (1) EP1185266A4 (en)
AU (1) AU4604000A (en)
IN (1) IN191492B (en)
WO (1) WO2000071124A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6613906B1 (en) 2000-06-06 2003-09-02 Geneva Pharmaceuticals, Inc. Crystal modification
CH695216A5 (en) * 2001-02-23 2006-01-31 Cilag Ag A method for manufacturing a non-hydrated salt of a piperidine derivative and a novel crystalline form thus obtainable of such a salt.
US20020177608A1 (en) * 2001-04-09 2002-11-28 Ben-Zion Dolitzky Polymorphs of fexofenadine hydrochloride
CA2646802A1 (en) * 2001-06-18 2002-12-27 Dr. Reddy's Laboratories Ltd. Novel crystalline forms of 4-[4-[4-(hydroxydiphenylmethyl)-1-piperidinyl]-1-hydroxybutyl]-.alpha.,.alpha.-dimethylbenzene acetic acid and its hydrochloride
AU2003248657A1 (en) 2002-06-10 2003-12-22 Teva Pharmaceutical Industries Ltd. Polymorphic form xvi of fexofenadine hydrochloride
ES2339682T3 (en) 2004-06-01 2010-05-24 Teva Gyogyszergyar Zartkoruen Mukodo Reszvenytarsasag PROCEDURE FOR THE PREPARATION OF THE AMORPHY FORM OF A PHARMACO.
EP2105134A1 (en) 2008-03-24 2009-09-30 Ranbaxy Laboratories Limited Stable amorphous fexofenadine hydrochloride
WO2011158262A1 (en) 2010-06-15 2011-12-22 Chemelectiva S.R.L. Polymorphic form of fexofenadine hydrochloride, intermediates and process for its preparation
KR101014010B1 (en) * 2010-12-30 2011-02-14 주식회사 한국에너지관리 Apparatus for mixing air bubble into water

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4562181A (en) * 1982-07-30 1985-12-31 Glaxo Group Limited Amorphous form of cefuroxime ester
EP0297580A1 (en) * 1987-07-01 1989-01-04 E.R. Squibb & Sons, Inc. Amorphous form of aztreonam
WO1995031437A1 (en) * 1994-05-18 1995-11-23 Hoechst Marrion Roussel, Inc. Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudormophs thereof
US5631375A (en) * 1992-04-10 1997-05-20 Merrell Pharmaceuticals, Inc. Process for piperidine derivatives
EP0810224A1 (en) * 1996-05-30 1997-12-03 Asahi Glass Company Ltd. Method of producing amorphous paroxetine hydrochloride
WO1998033789A1 (en) * 1997-02-04 1998-08-06 Sepracor, Inc. Synthesis of terfenadine and derivatives

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4254129A (en) * 1979-04-10 1981-03-03 Richardson-Merrell Inc. Piperidine derivatives
US4285957A (en) * 1979-04-10 1981-08-25 Richardson-Merrell Inc. 1-Piperidine-alkanol derivatives, pharmaceutical compositions thereof, and method of use thereof

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4562181A (en) * 1982-07-30 1985-12-31 Glaxo Group Limited Amorphous form of cefuroxime ester
EP0297580A1 (en) * 1987-07-01 1989-01-04 E.R. Squibb & Sons, Inc. Amorphous form of aztreonam
US5631375A (en) * 1992-04-10 1997-05-20 Merrell Pharmaceuticals, Inc. Process for piperidine derivatives
WO1995031437A1 (en) * 1994-05-18 1995-11-23 Hoechst Marrion Roussel, Inc. Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudormophs thereof
EP0810224A1 (en) * 1996-05-30 1997-12-03 Asahi Glass Company Ltd. Method of producing amorphous paroxetine hydrochloride
WO1998033789A1 (en) * 1997-02-04 1998-08-06 Sepracor, Inc. Synthesis of terfenadine and derivatives

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO0071124A1 *

Also Published As

Publication number Publication date
EP1185266A1 (en) 2002-03-13
IN191492B (en) 2003-12-06
AU4604000A (en) 2000-12-12
WO2000071124A1 (en) 2000-11-30

Similar Documents

Publication Publication Date Title
HU0000138D0 (en) Opioid analgetics retarded agent-releasing
AU1234002A (en) Crystalline forms of venlafaxine hydrochloride
AU140962S (en) A set of bottles
EP1289928A4 (en) Novel amorphous form of sertraline hydrochloride
EP1178788A4 (en) Novel diphenylethylene compounds
EP1185266A4 (en) Amorphous form of fexofenadine hydrochloride
IL153171A0 (en) Crystal modification of fexofenadine
SG80679A1 (en) Piezoelectric compinent
HK1022237A2 (en) An improved structure of a brush
AU140694S (en) A set of delineator brackets
PL353243A1 (en) An improved form of form i celiprolol hydrochloride
IL138390A0 (en) Crystalline form of paroxetine
PL332676A1 (en) Method of obtaining benzidamine hydrochloride
TW409717U (en) Improved structure of aerosol device
TW427590U (en) Improved structure of a wire-releasing box
TW428512U (en) Improved structure of a wrench
TW429799U (en) Structure of top
TW415628U (en) Improved structure of transformer
GB9904614D0 (en) Piperidines
TW511527U (en) Improved structure of gripper
TW431150U (en) Structure of toothbrush
TW369852U (en) Modified structure of a sofa-bed
TW457961U (en) Improved structure for racket
TW399438U (en) Improved structure of bedhead
TW465436U (en) Improved structure of tool box

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20011227

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

AX Request for extension of the european patent

Free format text: AL PAYMENT 20011227;LT PAYMENT 20011227;LV PAYMENT 20011227;MK PAYMENT 20011227;RO PAYMENT 20011227;SI PAYMENT 20011227

A4 Supplementary search report drawn up and despatched

Effective date: 20020603

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

RIC1 Information provided on ipc code assigned before grant

Free format text: 7C 07D 211/22 A, 7A 61K 31/445 B, 7A 61K 9/16 B, 7A 61K 9/19 B, 7B 01D 1/18 B

17Q First examination report despatched

Effective date: 20040212

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20040824